Credit Suisse’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.15M | Buy |
105,581
+1,410
| +1% | +$44.1K | ﹤0.01% | 1573 |
|
|
2023
Q4 | $3.33M | Buy |
104,171
+7,951
| +8% | +$231K | ﹤0.01% | 1577 |
|
|
2023
Q3 | $2.81M | Sell |
96,220
-1,909
| -2% | -$68.6K | ﹤0.01% | 1621 |
|
|
2023
Q2 | $4.41M | Buy |
98,129
+10,964
| +13% | +$418K | ﹤0.01% | 1422 |
|
|
2023
Q1 | $3M | Buy |
87,165
+11,447
| +15% | +$372K | ﹤0.01% | 1637 |
|
|
2022
Q4 | $2.11M | Buy |
75,718
+35,420
| +88% | +$938K | ﹤0.01% | 1837 |
|
|
2022
Q3 | $943K | Buy |
40,298
+6,129
| +18% | +$196K | ﹤0.01% | 2374 |
|
|
2022
Q2 | $988K | Buy |
34,169
+5,248
| +18% | +$229K | ﹤0.01% | 2397 |
|
|
2022
Q1 | $1.59M | Buy |
28,921
+6,053
| +26% | +$299K | ﹤0.01% | 2232 |
|
|
2021
Q4 | $1.22M | Sell |
22,868
-7,751
| -25% | -$359K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $1.3M | Buy |
30,619
+6,603
| +27% | +$337K | ﹤0.01% | 3138 |
|
|
2021
Q2 | $1.6M | Buy |
24,016
+2,048
| +9% | +$111K | ﹤0.01% | 3028 |
|
|
2021
Q1 | $973K | Sell |
21,968
-118
| -0.5% | -$4.38K | ﹤0.01% | 3343 |
|
|
2020
Q4 | $642K | Buy |
22,086
+4,451
| +25% | +$111K | ﹤0.01% | 3653 |
|
|
2020
Q3 | $386K | Buy |
17,635
+5,384
| +44% | +$95.7K | ﹤0.01% | 3524 |
|
|
2020
Q2 | $141K | Buy |
+12,251
| New | +$134K | ﹤0.01% | 3801 |
|
|
2020
Q1 | – | Sell |
-33,388
| Closed | -$522K | – | 4209 |
|
|
2019
Q4 | $522K | Sell |
33,388
-5,373
| -14% | -$60.9K | ﹤0.01% | 3538 |
|
|
2019
Q3 | $287K | Sell |
38,761
-61,557
| -61% | -$441K | ﹤0.01% | 3721 |
|
|
2019
Q2 | $817K | Buy |
100,318
+89,789
| +853% | +$895K | ﹤0.01% | 3080 |
|
|
2019
Q1 | $118K | Buy |
+10,529
| New | +$133K | ﹤0.01% | 3834 |
|
|
2018
Q3 | – | Sell |
-13,680
| Closed | -$204K | – | 3961 |
|
|
2018
Q2 | $204K | Sell |
13,680
-1,003
| -7% | -$16.8K | ﹤0.01% | 3759 |
|
|
2018
Q1 | $251K | Sell |
14,683
-620
| -4% | -$9.66K | ﹤0.01% | 3633 |
|
|
2017
Q4 | $185K | Sell |
15,303
-7,476
| -33% | -$71.5K | ﹤0.01% | 3762 |
|
|
2017
Q3 | $235K | Buy |
22,779
+12,584
| +123% | +$180K | ﹤0.01% | 3856 |
|
|
2017
Q2 | $232K | Sell |
10,195
-4,888
| -32% | -$101K | ﹤0.01% | 3577 |
|
|
2017
Q1 | $294K | Sell |
15,083
-37,158
| -71% | -$722K | ﹤0.01% | 3518 |
|
|
2016
Q4 | $828K | Buy |
52,241
+26,217
| +101% | +$436K | ﹤0.01% | 3151 |
|
|
2016
Q3 | $527K | Sell |
26,024
-20,341
| -44% | -$374K | ﹤0.01% | 3387 |
|
|
2016
Q2 | $830K | Buy |
46,365
+36,351
| +363% | +$541K | ﹤0.01% | 3077 |
|
|
2016
Q1 | $133K | Buy |
+10,014
| New | +$155K | ﹤0.01% | 3777 |
|
Other funds holding SGRY
BCI
DCP
DM
Credit Suisse's SGRY Position: Q1 2024 in Review
Credit Suisse increased its Surgery Partners (SGRY) stake by 1.4% in Q1 2024, buying an estimated $44.1K and bringing the position to 105,581 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1573.
Credit Suisse first reported a position in SGRY in Q1 2016 and has held it in 30 quarters since. The position peaked at $4.41M in Q2 2023. 180 funds tracked by Wall St. Rank hold SGRY as of Q1 2024.
- Credit Suisse held 105,581 shares of Surgery Partners worth $3.15M as of Q1 2024.
- Credit Suisse bought 1,410 Surgery Partners shares in Q1 2024, an estimated $44.1K.
- Surgery Partners made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1573 holding.
- Credit Suisse first reported a position in Surgery Partners in Q1 2016 and has held it in 30 quarters since.
- Credit Suisse's Surgery Partners position peaked at $4.41M in Q2 2023.
- 180 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.